Ventilation/perfusion ratio and right to left shunt in healthy newborn infants.

Related Articles

Ventilation/perfusion ratio and right to left shunt in healthy newborn infants.

J Clin Monit Comput. 2016 Dec 23;:

Authors: Dassios T, Ali K, Rossor T, Greenough A

Abstract
Oxygenation impairment can be assessed non-invasively by determining the degree of right-to-left shunt and ventilation/perfusion (VA/Q) inequality. These indices have been used in sick newborn infants, but normative values have not been reported which are essential to determine the magnitude of the abnormality. We, therefore, aimed to measure the shunt and VA/Q in infants with no history of respiratory conditions and determine if there was any effect of supine or prone position and the reproducibility of the data. Data were analysed from infants who had undergone a hypoxic challenge and in a subset who had been assessed in the supine or prone position. Transcutaneous oxygen saturations (SpO2) were recorded at fractions of inspired oxygen (FIO2) of 0.21 and 0.15. Two independent raters used a computer software algorithm which analysed and fitted paired data for FIO2 and SpO2 and derived a curve which represented the best fit for each infant’s data and calculated the shunt and VA/Q. The raters ability to interpret the SpO2 value which corresponded to a given FIO2 was compared. The downwards displacement of the FIO2 versus SpO2 curve was used to estimate the degree of right-to-left shunt and the rightwards shift of the curve was used to calculate the VA/Q ratio. The mean (SD) gestational age of the 145 infants was 39 (1.6) weeks, their birth weight was 2990 (578) gms and median (range) postnatal age at measurement 3 (1-8) days. The mean (SD) VA/Q ratio was 0.95 (0.21). None of the infants had a right-to-left shunt. No significant differences were found in VA/Q in the supine compared to the prone position. The intraclass correlation coefficient of VA/Q between two independent raters was 0.968 (95% CI 0.947-0.980), p?<?0.001. Right-to-left shunt and VA/Q ratio in healthy newborn infants were similar in the prone compared to the supine position.

PMID: 28012013 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

New guidelines: Introduce peanuts to infants early to prevent allergies

By Rob Goodier (Reuters Health) – Parents may be able to reduce the chance that their children will develop peanut allergies by introducing the food early on, as young as four to six months of age, experts now say. The timing and method should depend on the infant’s risk of a peanut allergy, according to doctors who presented a preview of updated guidelines today in San Francisco at the annual meeting of the American College of Allergy, Asthma and Immunology. “Guidance regarding when to introduce peanut into the diet of an infant is changing, based on new research that shows that early introduction around 4-6 months of life, after a few other foods have been introduced into the infant’s diet, is associated with a significantly reduced risk of such infants developing peanut allergy,” said Dr. Matthew Greenhawt, a pediatrician and co-director of the Food Challenge and Research Unit at Children’s Hospital Colorado in Aurora, Colorado, who coauthored the update.

View full post on Health News Headlines – Yahoo News

The severity of acute bronchiolitis in infants was associated with quality of life nine months later.

Related Articles

The severity of acute bronchiolitis in infants was associated with quality of life nine months later.

Acta Paediatr. 2016 Mar 11;

Authors: Rolfsjord LB, Skjerven HO, Carlsen KH, Mowinckel P, Bains KE, Bakkeheim E, Lødrup Carlsen KC

Abstract
AIM: Acute bronchiolitis in infancy increases the risk of later asthma and reduced health-related quality of life (QoL). We aimed to see if the severity of acute bronchiolitis in the first year of life was associated with QoL nine months later.
METHODS: The parents of 209 out of 404 of children hospitalised for acute bronchiolitis in eight paediatric departments in South-East Norway at a mean four months of age (range 0-12 months) completed the Infant Toddler Quality of Life Questionnaire sent by mail nine months after the acute illness. Disease severity was measured by length of stay and the need for supportive treatment. Interactions with gender, inclusion age, prematurity, maternal ethnicity and maternal education were examined.
RESULTS: Reduced QoL in four domains was associated with increased length of stay and need for ventilatory support. Physical abilities and general health were associated with both severity markers, whereas bodily pain and discomfort and change in health were associated with length of stay. Ventilatory support was more negatively associated with QoL than atopic eczema and also associated with reduced parental emotions and parental time.
CONCLUSION: The severity of acute bronchiolitis in infants was associated with reduced QoL nine months later. This article is protected by copyright. All rights reserved.

PMID: 26970427 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Identifying Mutations of the Tetratricopeptide Repeat Domain 37 (TTC37) Gene in Infants With Intractable Diarrhea and a Comparison of Asian and Non-Asian Phenotype and Genotype: A Global Case-report Study of a Well-Defined Syndrome With Immunodeficiency.

Related Articles

Identifying Mutations of the Tetratricopeptide Repeat Domain 37 (TTC37) Gene in Infants With Intractable Diarrhea and a Comparison of Asian and Non-Asian Phenotype and Genotype: A Global Case-report Study of a Well-Defined Syndrome With Immunodeficiency.

Medicine (Baltimore). 2016 Mar;95(9):e2918

Authors: Lee WI, Huang JL, Chen CC, Lin JL, Wu RC, Jaing TH, Ou LS

Abstract
Syndromic diarrhea/tricho-hepato-enteric syndrome (SD/THE) is a rare, autosomal recessive and severe bowel disorder mainly caused by mutations in the tetratricopeptide repeat domain 37 (TTC37) gene which act as heterotetrameric cofactors to enhance aberrant mRNAs decay. The phenotype and immune profiles of SD/THE overlap those of primary immunodeficiency diseases (PIDs).Neonates with intractable diarrhea underwent immunologic assessments including immunoglobulin levels, lymphocyte subsets, lymphocyte proliferation, superoxide production, and IL-10 signaling function. Candidate genes for PIDs predisposing to inflammatory bowel disease were sequencing in this study.Two neonates, born to nonconsanguineous parents, suffered from intractable diarrhea, recurrent infections, and massive hematemesis from esopharyngeal varices due to liver cirrhosis or accompanying Trichorrhexis nodosa that developed with age and thus guided the diagnosis of SD/THE compatible to TTC37 mutations (homozygous DelK1155H, Fs*2; heterozygous Y1169Ter and InsA1143, Fs*3). Their immunologic evaluation showed normal mitogen-stimulated lymphocyte proliferation, superoxide production, and IL-10 signaling, but low IgG levels, undetectable antibody to hepatitis B surface antigen and decreased antigen-stimulated lymphocyte proliferation. A PubMed search for bi-allelic TTC37 mutations and phenotypes were recorded in 14 Asian and 12 non-Asian cases. They had similar presentations of infantile onset refractory diarrhea, facial dysmorphism, hair anomalies, low IgG, low birth weight, and consanguinity. A higher incidence of heart anomalies (8/14 vs 2/12; P?=?0.0344, Chi-square), nonsense mutations (19 in 28 alleles), and hot-spot mutations (W936Ter, 2779-2G>A, and Y1169Ter) were found in the Asian compared with the non-Asian patients. Despite immunoglobulin therapy in 20 of the patients, 4 died from liver cirrhosis and 1 died from sepsis.Patients of all ethnicities with SD/THE with the characteristic triad of T nodosa, hepatic cirrhosis, and intractable enteropathy have low IgG, poor vaccine response and/or decreased antigen-stimulated lymphocyte proliferation. This is now better classified into the subgroup of “well-defined syndromes with immunodeficiency” (the update termed as “combined immunodeficiencies with associated or syndromic features”) than “predominantly antibody deficiencies” in the update PIDs classification, and requires optimal interventions.

PMID: 26945392 [PubMed – in process]

View full post on pubmed: asthma

Asthma Drug Use in Infants Tied to Stunted Growth – WebMD


Medical Daily

Asthma Drug Use in Infants Tied to Stunted Growth
WebMD
Medications called inhaled corticosteroids (ICS) that can treat conditions like asthma are often used in infants with recurrent wheezing. But a study of more than 12,000 Finnish babies found that those who were given these meds during the first 2 years
Infants' Asthma Treatment May Cause Stunted Growth, But Breathing Is More Medical Daily
(+Video) Infants who get treated for asthma have stunted growthNature World Report
Asthma steroids 'could stunt growth'BBC News
University Herald –Parent Herald –Tech Times
all 137 news articles »

View full post on asthma – Google News

Infants’ Asthma Treatment May Cause Stunted Growth, But Breathing Is More … – Medical Daily


Medical Daily

Infants' Asthma Treatment May Cause Stunted Growth, But Breathing Is More
Medical Daily
A study presented over the weekend at the 54th annual meeting of the European Society for Pediatric Endocrinology in Spain suggests that asthma treatment in the first two years of a child's life may lead to stunted growth. However, because childhood
(+Video) Infants who get treated for asthma have stunted growthNature World Report
Asthma Drug Use in Infants Tied to Stunted GrowthWebMD
Asthma steroids 'could stunt growth'BBC News
Parent Herald –NYC Today –Times Gazette
all 137 news articles »

View full post on asthma – Google News

(+Video) Infants who get treated for asthma have stunted growth – Nature World Report


Nature World Report

(+Video) Infants who get treated for asthma have stunted growth
Nature World Report
Researchers from Kuopio University Hospital and University of Eastern Finland analysed information on the height, weight and asthma medicine intake of 12,482 Finnish children aged 0-24 months. They found that children who used inhaled corticosteroids …
Asthma Medication May Stunt GrowthUniversity Herald
Asthma steroids 'could stunt growth'BBC News
Asthma Treatment to Children below Two Could Lead to Stunt GrowthTimes Gazette
NYC Today –The Standard Daily –StarmineNews.com
all 115 news articles »

View full post on asthma – Google News

(Video) Study: Infants treated for asthma before two have stunted growth – Nature World Report


Nature World Report

(Video) Study: Infants treated for asthma before two have stunted growth
Nature World Report
Finnish researchers suggested that infants given asthma medications during their first 2 years of age have a risk of stunted growth in later life. A report presented by 54th Annual European Society for Paediatric Endocrinology Meeting unveiled the
Asthma steroids 'could stunt growth'BBC News
Is your child taking asthma steroids? Researchers says Asthma medications The Standard Daily
Asthma medication stunts growth among infants: Finnish ResearchNYC Today
Times Gazette –Pioneer News –Morning Ticker
all 82 news articles »

View full post on asthma – Google News

Bacteria Can Prevent Asthma In Infants & Toxins Threaten Reproductive Health – 5newsonline.com


5newsonline.com

Bacteria Can Prevent Asthma In Infants & Toxins Threaten Reproductive Health
5newsonline.com
Infants can be protected from getting asthma if they acquire four types of gut bacteria by the time they are three months old. That's the finding of a new study from the University of British Columbia. Researchers say most babies naturally acquire

View full post on asthma – Google News